Literature DB >> 22778475

Chronic cystoid macular oedema treated with intravitreal dobesilate.

Pedro Cuevas1, Luis A Outeiriño, Javier Angulo, Guillermo Giménez-Gallego.   

Abstract

Dobesilate is an anti-inflammatory and antipermeability agent. Intravitreal administration of this compound is a therapeutically beneficial agent in the treatment of chronic cystoid macular oedema.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22778475      PMCID： PMC4543391          DOI： 10.1136/bcr-2012-006376

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  16 in total

Review 1.  The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.

Authors:  A J Flach
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 2.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

3.  Treatment of dry age-related macular degeneration with dobesilate.

Authors:  P Cuevas; L A Outeiriño; J Angulo; G Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-06-21

Review 4.  Cystoid macular edema: current modes of therapy.

Authors:  John Y Choi; Sheldon M Buzney; John J Weiter
Journal:  Int Ophthalmol Clin       Date:  2005

5.  Cystoid macular edema after phacoemulsification: risk factors and effect on visual acuity.

Authors:  Gokhan Gulkilik; Selim Kocabora; Muhittin Taskapili; Gunay Engin
Journal:  Can J Ophthalmol       Date:  2006-12       Impact factor: 1.882

6.  Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.

Authors:  Israel S Fernández; Pedro Cuevas; Javier Angulo; Pilar López-Navajas; Angeles Canales-Mayordomo; Rocío González-Corrochano; Rosa M Lozano; Serafín Valverde; Jesús Jiménez-Barbero; Antonio Romero; Guillermo Giménez-Gallego
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

Review 7.  Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery.

Authors:  Sobha Sivaprasad; Catey Bunce; Roxanne Crosby-Nwaobi
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

8.  Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.

Authors:  M A Genead; G A Fishman
Journal:  Eye (Lond)       Date:  2010-10-22       Impact factor: 3.775

9.  Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Christos Haritoglou; Joachim Gerss; Cristina Sauerland; Anselm Kampik; Michael W Ulbig
Journal:  Lancet       Date:  2009-04-18       Impact factor: 79.321

10.  A pro-inflammatory signature mediates FGF2-induced angiogenesis.

Authors:  Germán Andrés; Daria Leali; Stefania Mitola; Daniela Coltrini; Maura Camozzi; Michela Corsini; Mirella Belleri; Emilio Hirsch; Reto A Schwendener; Gerhard Christofori; Antonio Alcamì; Marco Presta
Journal:  J Cell Mol Med       Date:  2009-08       Impact factor: 5.295
View more
  1 in total

1.  Treatment of Stargardt disease with dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-10-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.